Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02177292 · ClinicalTrials.gov registry record · NA

High-Dose Lymph Node Intensity Modulated Radiation Therapy and Hypofractionated Prostate (SIB)

A NA study of Prostate Cancer, sponsored by Medical College of Wisconsin.

Active
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT02177292 is a NA study of Prostate Cancer that is active but no longer recruiting, run by Medical College of Wisconsin. The registered enrollment target is 80 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02177292, a NA study of Prostate Cancer, is active but no longer recruiting, sponsored by Medical College of Wisconsin.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to find out the effects (good and bad) of using newer technologies that allow very precise delivery of radiation. These newer technologies are Intensity Modulated Radiation Therapy (IMRT) and Image Guided Radiation Therapy (IGRT).

Conditions Studied

Interventions

  • RADIATION Radiation Therapy

Study Locations (1)

Wisconsin

  • Froedtert & the Medical College of Wisconsin - Milwaukee

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2010-06-23
Est. Completion 2030-06-21
Phase NA

Sponsor

Medical College of Wisconsin

447 total trials

What the Registry Record Tells You About NCT02177292

The ClinicalTrials.gov registry entry for NCT02177292 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (87% lower). The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which Radiation Therapy is the first listed.

NCT02177292 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.

Frequently Asked Questions

What is clinical trial NCT02177292 about?

NCT02177292 is a clinical study titled "High-Dose Lymph Node Intensity Modulated Radiation Therapy and Hypofractionated Prostate (SIB)". The purpose of this study is to find out the effects (good and bad) of using newer technologies that allow very precise delivery of radiation. These newer technologies are Intensity Modulated Radiation Therapy (IMRT) and Image Guided Radiation Therapy (IGRT).

What is the current status of trial NCT02177292?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2010-06-23. Estimated completion is 2030-06-21.

What conditions does trial NCT02177292 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT02177292?

The interventions under investigation include: Radiation Therapy (RADIATION).

Who is sponsoring clinical trial NCT02177292?

This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02177292 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.